The trial of a new drug, bexobrutideg, shows promising results for chronic lymphocytic leukemia patients previously treated ...

In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

About 15 months after breaking ground in earnest, Geisinger’s state-of-the-art cancer center in the borough will welcome its ...

Each year, ECU Health and the Department of Pediatrics Hematology/Oncology at the Brody School of Medicine at East Carolina ...

Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— breast cancer.

When it comes to cancer, although treatment is essential, it is often exhausting, long, and strenuous on the body, but ...

And donating blood three times per year could possibly save you, according to researchers at the Francis Crick Institute in ...

Physicians from Bochum have used a cancer treatment method to treat severe autoimmune diseases.

First use of camel hemoglobin as a universal oxygen carrier - Unique properties make it an ideal ingredient for oxygen transport. BOSTON, MASSACHUSETTS, (GLOBE NEW ...

CEPHEUS trial lead investigator Saad Z. Usmani, MD, MBA, FACP, FASCO, explains how the trial both builds on current knowledge of newly diagnosed multiple myeloma and how transplant-ineligible status ...

The Columbus startup received FDA approval and has a clinical trial underway for a therapy targeting acute lymphoblastic ...

JOHNSON CITY — In an ongoing commitment to increase access to quality oncology and hematology services in the Appalachian ...